CA2289441A1 - Green porphyrins as immunomodulators - Google Patents

Green porphyrins as immunomodulators Download PDF

Info

Publication number
CA2289441A1
CA2289441A1 CA002289441A CA2289441A CA2289441A1 CA 2289441 A1 CA2289441 A1 CA 2289441A1 CA 002289441 A CA002289441 A CA 002289441A CA 2289441 A CA2289441 A CA 2289441A CA 2289441 A1 CA2289441 A1 CA 2289441A1
Authority
CA
Canada
Prior art keywords
antigen
light
subject
bpd
green
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002289441A
Other languages
English (en)
French (fr)
Inventor
Agnes Chan
David W.C. Hunt
Guillermo O. Simkin
Julia G. Levy
Modestus O.K. Obochi
Anna M. Richter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Novelion Therapeutics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/856,921 external-priority patent/US6008241A/en
Application filed by Individual filed Critical Individual
Publication of CA2289441A1 publication Critical patent/CA2289441A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F132/00—Homopolymers of cyclic compounds containing no unsaturated aliphatic radicals in a side chain, and having one or more carbon-to-carbon double bonds in a carbocyclic ring system
    • C08F132/08—Homopolymers of cyclic compounds containing no unsaturated aliphatic radicals in a side chain, and having one or more carbon-to-carbon double bonds in a carbocyclic ring system having condensed rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002289441A 1997-05-16 1998-05-15 Green porphyrins as immunomodulators Abandoned CA2289441A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/856,921 US6008241A (en) 1995-01-17 1997-05-16 Green porphyrins as immunomodulators
US08/856,921 1997-05-16
PCT/CA1998/000484 WO1998052608A1 (en) 1997-05-16 1998-05-15 Green porphyrins as immunomodulators

Publications (1)

Publication Number Publication Date
CA2289441A1 true CA2289441A1 (en) 1998-11-26

Family

ID=25324780

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002289441A Abandoned CA2289441A1 (en) 1997-05-16 1998-05-15 Green porphyrins as immunomodulators

Country Status (6)

Country Link
EP (1) EP0981371A1 (ja)
JP (1) JP2000516964A (ja)
CN (1) CN1149101C (ja)
AU (1) AU7422098A (ja)
CA (1) CA2289441A1 (ja)
WO (1) WO1998052608A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6364907B1 (en) 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4838852A (en) * 1987-03-27 1989-06-13 Therakos, Inc. Active specific immune suppression
EP0804238B1 (en) * 1995-01-13 2004-09-29 QLT Inc. Method to prevent transplant rejection
US5789433A (en) * 1995-01-17 1998-08-04 Quadra Logic Technologies, Inc. Green porphyrins as immunomodulators
AU7237896A (en) * 1995-09-06 1997-03-27 Research Foundation Of The State University Of New York, The Two-photon upconverting dyes and applications

Also Published As

Publication number Publication date
WO1998052608A1 (en) 1998-11-26
EP0981371A1 (en) 2000-03-01
CN1255863A (zh) 2000-06-07
JP2000516964A (ja) 2000-12-19
AU7422098A (en) 1998-12-11
CN1149101C (zh) 2004-05-12

Similar Documents

Publication Publication Date Title
US6008241A (en) Green porphyrins as immunomodulators
US6107325A (en) Green porphyrins as immunomodulators
EP0983273B1 (en) Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents
Calzavara‐Pinton et al. Photodynamic therapy: update 2006 Part 1: Photochemistry and photobiology
US4753958A (en) Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
Spikes New trends in photobiology: Chlorins as photosensitizers in biology and medicine
Fingar et al. The effects of photodynamic therapy using differently substituted zinc phthalocyanines on vessel constriction, vessel leakage and tumor response
Van Henegouwen Medicinal photochemistry: phototoxic and phototherapeutic aspects of drugs
Morgan et al. Metallopurpurins and light: effect on transplantable rat bladder tumors and murine skin
CA2270558C (en) Treatment of autoimmune diseases by photochemotherapy
Simkin et al. Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative
Manyak et al. Protection against dihematoporphyrin ether photosensitivity
CA2289441A1 (en) Green porphyrins as immunomodulators
Simkin et al. Effect of photodynamic therapy using benzoporphyrin derivative on the cutaneous immune response
US6756396B1 (en) Ethylene glycol esters as photoactive agents
Richter et al. Photodynamic treatment with BPD-MA (verteporfin) activated with light within different spectral ranges
JP3574456B6 (ja) 免疫調節剤としての緑色ポルフィリン
Brown et al. Cancer and porphyrins—photochemotherapy
MXPA97005376A (en) Raw porfirines as immunomodulated
MXPA99010169A (es) Esteres de etilenglicol de derivados de monohidrobenzoporfirina como agentes fotoactivos

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead